Difficulties of diagnosis and management tactics of COVID-19 in HIV-infected patients in a non-infectious hospital

Abstract

The spread of COVID-19 over the past three years has posed difficult tasks for doctors related to rapid diagnosis and provision of highly qualified medical care to patients, including with co-infection ― SARS-CoV-2/human immunodeficiency virus.

The analysis of the combined course of COVID-19 and human immunodeficiency virus demonstrated the synergistic effect of SARS-CoV-2 and human immunodeficiency virus on the human body. Numerous studies have shown that COVID-19 is more severe and is accompanied by high mortality in older people and in the presence of comorbid pathology. Including important role belongs to diseases accompanied by suppression of cellular immunity, which lead to frequent complications and longer viremia, which can be observed with human immunodeficiency virus infection. The similarity of clinical, laboratory and radiological data does not allow to differentiate COVID-19 and human immunodeficiency virus opportunistic diseases with lung damage (pneumocystic pneumonia, cytomegalovirus and candidiasis etiology), in an early period, especially in patients without an established human immunodeficiency virus status.

Identification of the features of the course of the disease, alertness towards human immunodeficiency virus infection in patients admitted to the hospital with COVID-19 at a young age, the peculiarities of the epidemiological history will allow early diagnosis and improve management tactics.

Keywords

human immunodeficiency virus / combined infection of SARS-CoV-2/HIV / COVID-19 / HIV infection / pneumonia / comorbid diseases

References

[1] Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–95. doi: 10.1016/j.ijid.2020.03.017

[2] Yang J., Zheng Y., Gou X., et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis // Int J Infect Dis. 2020. Vol. 94. Р. 91–95. doi: 10.1016/j.ijid.2020.03.017

[3] Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;17(323):1061–1069. doi: 10.1001/jama.2020.1585

[4] Wang D., Hu B., Hu C., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China // JAMA. 2020. Vol. 17, N 323. Р. 1061–1069. doi: 10.1001/jama.2020.1585

[5] Lee KW, Yap SF, Ngeow YF, Lye MS. COVID-19 in people living with HIV: a systematic review and meta-analysis. Int J Environ Res Public Health. 2021;18(7):3554. doi: 10.3390/ijerph18073554

[6] Lee K.W., Yap S.F., Ngeow Y.F., Lye M.S. COVID-19 in people living with HIV: a systematic review and meta-analysis // Int J Environ Res Public Health. 2021. Vol. 18, N 7. Р. 3554. doi: 10.3390/ ijerph18073554

[7] Dolgova NN, Ryndich AA, Suladze AG, et al. Some clinical and epidemiological aspects of COVID-19 in people living with HIV. Infectious diseases: news, opinions, training. 2022;11(1):41–46. (In Russ). doi: 10.33029/2305-3496-2022-11-1-41-46

[8] Долгова Н.Н., Рындич А.А., Суладзе А.Г., и др. Некоторые клинические и эпидемиологические аспекты COVID-19 у людей, живущих с ВИЧ // Инфекционные болезни: новости, мнения, обучение. 2022. Т. 11, № 1. С. 41–46. doi: 10.33029/2305-3496-2022-11-1-41-46

[9] Mazus AI, Nagibina MV, Bessarab TP, et al. COVID-19/HIV co-infection: characteristics of patients of the Moscow megalopolis. Therapy. 2021;7(4):18–24. (In Russ). doi: 10.18565/therapy.2021.4.18-24

[10] Мазус А.И., Нагибина М.В., Бессараб Т.П., и др. COVID-19/ВИЧ-коинфекция: характеристика пациентов Московского мегаполиса // Терапия. 2021. Т. 7, № 4. С. 18–24. doi: 10.18565/therapy.2021.4.18-24

[11] Blanco JL, Reyes-Urueña JM, Sued O, et al. Overview of SARS-CoV-2 infection in adults living with HIV. Lancet HIV. 2021;8(5):e294–e305. doi: 10.1016/S2352-3018(21)00070-9

[12] Blanco J.L., Reyes-Urueña J.M., Sued O., et al. Overview of SARS-CoV-2 infection in adults living with HIV // Lancet HIV. 2021. Vol. 8, N 5. Р. e294–e305. doi: 10.1016/S2352-3018(21)00070-9

[13] Sergevnin VI, Sarmometov EV, Rozhkova MV. Prevalence and severity of the clinical course of a new coronavirus infection among HIV-infected people in comparison with the general population. Epidemiology and Vaccination Prevention. 2021;20(3):30–36. (In Russ). doi: 10.31631/2073-3046-2021-20-3-30-36

[14] Сергевнин В.И., Сармометов Е.В., Рожкова М.В. Распространенность и тяжесть клинического течения новой коронавирусной инфекции среди ВИЧ-инфицированных в сравнении с общей популяцией // Эпидемиология и вакцинопрофилактика. 2021. Т. 20, № 3. С. 30–36. doi: 10.31631/2073-3046-2021-20-3-30-36

[15] Vizcarra P, Pérez-Elías M, Quereda C, et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020;7(8):554–564. doi: 10.1016/S2352-3018(20)30164

[16] Vizcarra P., Pérez-Elías M., Quereda C., et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort // Lancet HIV. 2020. Vol. 7, N 8. Р. 554–564. doi: 10.1016/S2352-3018(20)30164

[17] Mirzaei H, McFarland W, Karamouzian M, Sharifi H. COVID-19 among people living with HIV: a systematic review. AIDS Behav. 2021;25(1):85–92. doi: 10.1007/s10461-020-02983-2

[18] Mirzaei H., McFarland W., Karamouzian M., Sharifi H. COVID-19 among people living with HIV: a systematic review // AIDS Behav. 2021. Vol. 25, N 1. Р. 85–92. doi: 10.1007/s10461-020-02983-2

RIGHTS & PERMISSIONS

Eco-vector